Mercado de agentes de medios de contraste: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001102
  • Category : Life Sciences
  • No. of Pages : 177
Buy Now

Se prevé que el mercado de agentes de medios de contraste alcance los 8.391,1 millones de dólares en 2031 desde los 5.599,6 dólares de los EE.UU. millones en 2022; se espera que crezca a una tasa compuesta anual del 7,0 % entre 2022 y 2031.

Los agentes de contraste son sustancias que se utilizan para mejorar la radiodensidad de un tejido objetivo alterando la forma de paso de las ondas ultrasónicas o la radiación electromagnética a través del cuerpo. Estas sustancias se pueden administrar por vía rectal, oral o intravenosa. La selección del tipo de agente de contraste depende de la modalidad y el propósito de la obtención de imágenes. La creciente prevalencia de enfermedades crónicas, el creciente número de aprobaciones de agentes de contraste y la evolución de las modalidades de diagnóstico por imágenes se encuentran entre los factores clave que contribuyen al crecimiento del mercado. Sin embargo, los efectos secundarios de los agentes de contraste dificultan su uso.

El mercado de agentes de medios de contraste está segmentado en en función del tipo, movilidad de las imágenes, indicación, vía de administración y geografía. El informe ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo (de los principales actores del mercado).

Perspectivas estratégicas

regiones lucrativas para el mercado de agentes de medios de contraste

Contrast Media Agents Market

Perspectivas del mercado

< h3>El aumento de la incidencia y prevalencia de trastornos crónicos impulsa el crecimiento del mercado

Las enfermedades cardiovasculares, respiratorias y ortopédicas crónicas, así como diversos tipos de cáncer, provocan discapacidades y mortalidad mundial. Estas condiciones clínicas afectan la calidad de vida general. Según la Organización Mundial de la Salud (OMS), se estima que aproximadamente el 50% de la población mundial padece al menos una enfermedad crónica. Los Centros para el Control y la Prevención de Enfermedades (CDC) afirmaron que 6 de cada 10 personas en EE. UU. sufrieron al menos una enfermedad crónica en 2021. Las enfermedades cardiovasculares (ECV) son una causa importante de mortalidad a nivel mundial. Según la Asociación Estadounidense del Corazón, en los EE. UU. la incidencia de insuficiencia cardíaca está aumentando. En 2021, ~ 874,613 personas murieron debido a enfermedades cardiovasculares en los EE. UU. Según un artículo publicado por Single Care, más de 350 millones de personas en el mundo vivían con artritis en 2021. Estados Unidos, Japón, Corea del Sur, Canadá, Reino Unido, España y Francia (junto con China, India, Arabia Saudita, Emiratos Árabes Unidos y Brasil) están presenciando un crecimiento sustancial de la población geriátrica, que tiene un mayor riesgo de sufrir artritis. Por lo tanto, la creciente prevalencia de enfermedades crónicas crea la necesidad de sistemas de diagnóstico seguros, eficaces y eficientes, como los rayos X/TC, imagen por resonancia magnética y ultrasonido, que, a su vez, está impulsando el crecimiento del mercado mundial de agentes de medios de contraste.

< h3>Ruta de conocimientos basados en la administración

Según la vía de administración, el mercado de agentes de medios de contraste se segmenta en intravascular, oral y rectal. El segmento intravascular tuvo la mayor participación de mercado en 2022 y se espera que registre la CAGR más alta durante el período de pronóstico. El crecimiento del mercado de este segmento se atribuye al amplio uso de las inyecciones de medios de contraste debido a su capacidad de administrar sustancias a cualquier parte del cuerpo.

Información basada en modalidades de imágenes

Según la modalidad de imagen, el mercado de agentes de medios de contraste se segmenta en rayos X/TC, imágenes por resonancia magnética y ultrasonido. El segmento de rayos X/TC representó la mayor cuota de mercado en 2022. Sin embargo, se prevé que el segmento de ultrasonido registre la CAGR más alta durante 2022-2031.

América del Norte tiene una participación importante en el mercado de agentes de medios de contraste y se espera que muestre una tendencia similar durante el período de pronóstico. Estados Unidos es el mayor consumidor de medios de contraste en esta región. El primer agente de contraste a base de gadolinio fue aprobado en Estados Unidos. Además, cuatro agentes más recibieron la aprobación de la FDA en Estados Unidos en la última década, lo que indica una fuerte inclinación hacia la introducción de agentes más eficientes, seguros y precisos en el país. Además, un aumento en la incidencia de enfermedades crónicas, como enfermedades neurológicas y cardiovasculares, es el factor principal que impulsa el crecimiento del mercado de agentes de medios de contraste en Estados Unidos. La demanda de medios de contraste es considerablemente alta en las técnicas de ultrasonido entre todas las modalidades de imagen.  

El mercado de agentes de medios de contraste está segmentado según el tipo , modalidad de imagen, indicación, vía de administración y geografía. Según el tipo, el mercado se segmenta en medios de contraste yodados, medios de contraste a base de gadolinio, medios de contraste a base de bario y medios de contraste de microburbujas. En términos de modalidad de imagen, el mercado se divide en rayos X/TC, resonancia magnética y ultrasonido. Según la indicación, el mercado se segmenta en trastornos cardiovasculares, cáncer, trastornos gastrointestinales, trastornos musculoesqueléticos, trastornos neurológicos y trastornos nefrológicos. El mercado de agentes de contraste, según la vía de administración, se segmenta en intravascular, oral y rectal. Según la geografía, el mercado está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y resto de Europa), Asia Pacífico (China, Japón, India, Corea del Sur). , Australia y resto de Asia Pacífico), Oriente Medio y Asia. África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y resto de Centro y Suramérica).

Perfiles de empresas

  • General Electric
  • Bayer AG
  • Bracco
  • Guerbet
  • Lantheus Medical Imaging Inc< /span>
  • nanoPET Pharma GmbH
  • Unijules Life Science Ltd
  • Magnus Health Management Pvt Ltd
  • JB Chemical and Pharmaceuticals Ltd
  • Jodan Expoim
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of Contrast media agent market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are the key players in contrast media agents market?

General Electric, Bayer AG, Bracco, GUERBET, Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Unijules Life Sciences Ltd, Magnus Health Management Pvt Ltd are key players in this market

What are future trends in contrast media agents market?

The trend shaping the radiological contrast media market includes the adoption of advanced imaging techniques, an increase in the prevalence of chronic diseases, and the older population, changing regulatory standards, a shift toward personalized medicine, and integration of digital technologies. Such factors, together, keep driving innovation and widening the scope of use of the contrast media agents and set this market on track for significant growth over the next few years.

What is expected CAGR of Contrast media agent market?

The market is expected to register a CAGR of 7.8% during 2023-2031

What are the factors impacting on contrast media agents market?

Major driving factors for the Contrast Media Agents Market include the prevalence of chronic diseases, aging of the population, improvement in technology related to imaging modalities, rise in the number of diagnostic procedures, innovative regulations, a focus on personalized medicine, and better awareness of early diagnosis of diseases. All these factors combined present a very strong environment where the growth and evolution of the contrast media agents market can thrive.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. General Electric

2. Bayer AG

3. Bracco

4. GUERBET

5. Lantheus Medical Imaging, Inc.

6. nanoPET Pharma GmbH

7. Unijules Life Sciences Ltd.

8. Magnus Health Management Pvt Ltd.

9. J.B.Chemicals and Pharmaceuticals Ltd.

10. Jodas Expoim


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.